Xiaojuan Xiao

1.5k total citations
55 papers, 1.0k citations indexed

About

Xiaojuan Xiao is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Xiaojuan Xiao has authored 55 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 15 papers in Hematology and 8 papers in Oncology. Recurrent topics in Xiaojuan Xiao's work include Multiple Myeloma Research and Treatments (13 papers), Ubiquitin and proteasome pathways (6 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). Xiaojuan Xiao is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Ubiquitin and proteasome pathways (6 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). Xiaojuan Xiao collaborates with scholars based in China, United States and Netherlands. Xiaojuan Xiao's co-authors include Jing Liu, Mao Ye, Long Liang, Mridul Roy, Peifu Feng, Ji Zhang, Hongling Peng, Zi Wang, Weihua Zhou and Xuan Luo and has published in prestigious journals such as Blood, PLoS ONE and Biomaterials.

In The Last Decade

Xiaojuan Xiao

54 papers receiving 1.0k citations

Peers

Countries citing papers authored by Xiaojuan Xiao

Since Specialization

Citations

This map shows the geographic impact of Xiaojuan Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojuan Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojuan Xiao more than expected).

Fields of papers citing papers by Xiaojuan Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojuan Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojuan Xiao. The network helps show where Xiaojuan Xiao may publish in the future.

Co-authorship network of co-authors of Xiaojuan Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojuan Xiao. A scholar is included among the top collaborators of Xiaojuan Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojuan Xiao. Xiaojuan Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single-cell sequencing analysis of multiple myeloma heterogeneity and identification of new theranostic targets 2024 ·Cell Death and Disease ·Yanpeng Wang, (unknown), (unknown), (unknown), Zeyuan Wang, Hongling Peng, Xusheng Wu, Xiaojuan Xiao, Jing Liu	3
2	Effects of ICU diaries on psychological disorders and sleep quality in critically ill patients and their family members: A systematic review and meta-analysis 2024 ·Sleep Medicine ·(unknown), Yang Gao, Lingjun Zhou, Xiaojuan Xiao, Hong Xu, (unknown), (unknown), Juan Wu	3
3	The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies 2023 ·Cancers ·Yu Zhu, Zi Wang, Yanan Li, Hongling Peng, Jing Liu, Ji Zhang, Xiaojuan Xiao	43
4	Anti-BCMA surface engineered biomimetic photothermal nanomissile enhances multiple myeloma cell apoptosis and overcomes the disturbance of NF-κB signaling in vivo 2023 ·Biomaterials ·Xiaojuan Xiao, (unknown), Zhenzhen Li, (unknown), Yibin Zhang, (unknown), Lin Zhu, (unknown), Hui Li, (unknown), (unknown), (unknown), Hongling Peng, Xifeng Liu, Haiqin Wang, Mao Ye, Yuetao Zhao, Jing Liu	12
5	Periplocin Overcomes Bortezomib Resistance by Suppressing the Growth and Down-Regulation of Cell Adhesion Molecules in Multiple Myeloma 2023 ·Cancers ·(unknown), Haiqin Wang, Yanpeng Wang, Zhenzhen Li, (unknown), (unknown), Xiaojuan Xiao, Jing Liu	3
6	HIF-PH Encoded by EGLN1 Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia 2022 ·Pharmaceuticals ·(unknown), (unknown), Peilong Wang, (unknown), Huifang Zhang, Xing Cheng, (unknown), Yinghua Wu, Heng Li, Zhao Cheng, Xiaojuan Xiao, Jing Liu, (unknown), Hongling Peng	2
7	A Ferroptosis Molecular Subtype‐Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic Leukemia 2022 ·BioMed Research International ·(unknown), Heng Li, Qin Yang, Guanxiong Zhang, Hong Liu, (unknown), Hongling Peng, (unknown), Xiaojuan Xiao, Jing Liu	14
8	LncRNA BC200/miR-150-5p/MYB positive feedback loop promotes the malignant proliferation of myelodysplastic syndrome 2022 ·Cell Death and Disease ·Zhaoping Liu, Pan Wang, Shunling Yuan, Yanyan Wang, Pengfei Cao, Feng Wen, Hui Li, Lin Zhu, Long Liang, Zi Wang, Bin Hu, (unknown), Jing Liu, Xiaojuan Xiao, Ji Zhang	9
9	Protocol for developing the reporting guidelines for radiological case reports: Case Report for Radiology statement 2022 ·Annals of Translational Medicine ·(unknown), Ying Zhu, Xufei Luo, Xiaojuan Xiao, Ling Wang, Meng Lv, Qi Wang, Yaolong Chen, Junqiang Lei, (unknown)	3
10	Identification and Characterization of Multiple Myeloma Stem Cell-Like Cells 2021 ·Cancers ·(unknown), Haiqin Wang, Peng Chen, (unknown), Boxin Zhang, Jing Liu, Hongling Peng, Xiaojuan Xiao	14
11	Protein mass spectrometry reveals lycorine exerting anti-multiple-myeloma effect by acting on VDAC2 and causing mitochondrial abnormalities 2021 ·Biotechnology Letters ·Hui Yi, (unknown), (unknown), (unknown), (unknown), Peng Chen, Lei Hu, Long Liang, (unknown), Xiaojuan Xiao, Jing Liu	1
12	Lycorine targets multiple myeloma stem cell‐like cells by inhibition of Wnt/β‐catenin pathway 2020 ·British Journal of Haematology ·(unknown), (unknown), Long Liang, Ling Xiao, Hui Yi, Mao Ye, Mridul Roy, Jiliang Xia, Wen Zhou, (unknown), (unknown), Boxin Zhang, Zhenzhen Li, Jing Liu, Hui Zhou, Xiaojuan Xiao	16
13	The Wee1 kinase inhibitor MK1775 suppresses cell growth, attenuates stemness and synergises with bortezomib in multiple myeloma 2020 ·British Journal of Haematology ·Long Liang, Yanjuan He, (unknown), Hui Zhou, Ling Xiao, Mao Ye, (unknown), (unknown), (unknown), Peifu Feng, (unknown), Wenjie Cao, Taohua Liu, Mridul Roy, Xiaojuan Xiao, Jing Liu	17
14	Antitumor Drug Combretastatin-A4 Phosphate Aggravates the Symptoms of Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice 2020 ·Frontiers in Pharmacology ·(unknown), (unknown), (unknown), Mao Ye, (unknown), Zi Wang, Lei Zhang, Xiaojuan Xiao	7
15	Multi-organ Dysfunction in Patients with COVID-19: A Systematic Review and Meta-analysis 2020 ·Aging and Disease ·Ting Wu, Zhihong Zuo, Shuntong Kang, Liping Jiang, Xuan Luo, Zanxian Xia, Jing Liu, Xiaojuan Xiao, Mao Ye, Meichun Deng	88
16	Association between high-resolution MRI-detected extramural vascular invasion and tumour microcirculation estimated by dynamic contrast-enhanced MRI in rectal cancer: preliminary results 2019 ·BMC Cancer ·Yan Chen, Xinyue Yang, (unknown), Yiyan Liu, Baolan Lu, (unknown), Xiaojuan Xiao	20
17	Non-invasive MR assessment of the microstructure and microcirculation in regional lymph nodes for rectal cancer: a study of intravoxel incoherent motion imaging 2019 ·Cancer Imaging ·Xinyue Yang, Yan Chen, (unknown), Yiyan Liu, Xiaojuan Xiao, (unknown), (unknown)	11
18	Targeting c‐met receptor tyrosine kinase by the DNA aptamer SL1 as a potential novel therapeutic option for myeloma 2018 ·Journal of Cellular and Molecular Medicine ·Yibin Zhang, Hongmei Gao, Weihua Zhou, (unknown), (unknown), Hui Zhang, Long Liang, Xiaojuan Xiao, (unknown), Mao Ye, Yujia Yang, Jingfeng Zhao, Zi Wang, Jing Liu	21
19	Fat-suppressed gadolinium-enhanced isotropic high-resolution 3D-GRE-T1WI for predicting small node metastases in patients with rectal cancer 2018 ·Cancer Imaging ·Yan Chen, Xinyue Yang, (unknown), Baolan Lu, Xiaojuan Xiao, Bingqi Shen, (unknown)	8
20	Laparoscopic versus open surgery for colon cancer: A meta-analysis of 5-year follow-up outcomes 2013 ·Surgical Oncology ·(unknown), Li Yan, (unknown), Xiaojuan Xiao, Jie Shi, Yan Zhang, Xiaoqin Yang, Peng Gao, Ke Zhang, Yuan Yuan, Dongzhi Zhang, Xiaodong Wei, (unknown), Jianping Wang, Xuebin Wang, Yingmei Zhang, Hui Cai	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact